Phillips Medisize: Chippenham Facility Acquisition Expands Global Inhalation Drug Delivery Manufacturing
· pulse2.com · popularity 16/100 · 0 similar stories today · Entrepreneurship & Startups (Business & Finance)
Read the original at pulse2.com →
Summary
Phillips Medisize, a Molex company specializing in medical technology and pharmaceutical drug delivery manufacturing, has acquired the full footprint of its Chippenham facility in England. The investment strengthens its Global Inhalation Center of Excellence and provides additional capacity for developing and manufacturing inhaled drug delivery products. The post Phillips Medisize: Chippenham Facility Acquisition Expands Global Inhalation Drug Delivery Manufacturing appeared first on Pulse 2.0 .
Found in: Pulse 2.0. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 16.